Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
Clinical trial NCT00055562 · COMPLETED
Trial details
- NCT number
- NCT00055562
- Sponsor
- Celgene Corporation
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.